Galderma announces positive data from OLYMPIA open-label extension study of Nemluvio in moderate-to-severe prurigo nodularis: Zug, Switzerland Monday, March 2, 2026, 15:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results